Skip to content

F. Awouters

2 papers in the library · 197 citations · publishing 1983-1988

Papers

Sort Most recent Most cited

Pharmacological profile of ritanserin: A very specific central serotonin S2‐antagonist

Drug Development Research 1988 F. Awouters, C. J. E. Niemegeers, Anton A. H. P. Megens et al. 139 citations

Abstract Ritanserin, a novel methylenepiperidine derivative, was studied in a wide range of common pharmacological tests mainly in rats. The lowest ED 50 , 0.0070 mg/kg, was obtained against tryptamine‐induced cyanosis. At 0.037 mg/kg, tryptamine‐induced bilateral clonic seizures were inhibited. Slightly higher doses, up to 0.11 mg/kg, inhibited mescaline and 5‐hydroxytryptophan (5‐HTP)‐induced...

DOI: 10.1002/ddr.430150107 (opens in new tab) Serotonin Ritanserin Tryptamine Antagonism +6

Mescaline‐induced head‐twitches in the rat: An in vivo method to evaluate serotonin S2 antagonists

Drug Development Research 1983 C. J. E. Niemegeers, Françis C. Colpaert, J.e. Leysen et al. 58 citations

Abstract An intravenous dose of 20.0 mg/kg of mescaline induced a reproducible head‐twitch response in rats. Drugs with very different pharmacological activities were tested for potential inhibition of this response. Among these drugs were a large number of serotonin antagonists, including several members of the recently described selective S 2 antagonists of which ketanserin (a potent vascular...

DOI: 10.1002/ddr.430030203 (opens in new tab) Mescaline Ketanserin Pharmacology Spiperone +11